- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05897931
Effects of Two Different Applications in Fibromyalgia
July 9, 2023 updated by: Eylül Pınar KISA, Biruni University
Effects of Connective Tissue Massage and Taping in Patients With Fibromyalgia
The study aims to determine the effect of connective tissue massage and taping applications on the pain and depression complaints of fibromyalgia patients and to compare their impact on quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Eylül Pınar Kısa, PhD
- Phone Number: 05321307023
- Email: ekisa@biruni.edu.tr
Study Contact Backup
- Name: Begüm KARA KAYA, MSc
- Phone Number: +905355720021
- Email: bkara@biruni.edu.tr
Study Locations
-
-
-
Istanbul, Turkey
- Yeditepe University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Being diagnosed with fibromyalgia.
- Be in the age range of 20 - 55 years.
- To be a volunteer participant in the research.
- Being able to communicate comfortably.
- To be able to act independently.
Exclusion Criteria:
- Having had a surgical operation within the last year.
- Presence of significant infection.
- Being diagnosed with cancer.
- Being pregnant or breastfeeding.
- Being addicted to drugs or alcohol.
- Having a cognitive problem.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Connective tissue massage
Participants will receive TENS and infrared treatment for 25 minutes, 5 days a week.
Then Connective Tissue Massage will be applied.
|
Connective Tissue Massage will be applied by starting from the lumbosacral region, continuing from the lower thoracic region, and finishing by applying it to the scapular region, interscapular region, and cervico-occipital region.
|
Experimental: Kinesio Tape Application
Participants will receive TENS and infrared treatment for 25 minutes, 5 days a week.
Kinesio tape application will be applied 2 days a week for 4 weeks.
|
Taping will be applied to the levator scapula and upper trapezius muscles in a "Y" shape, with 25% tension and while the participants were in an upright position.
Again in the same position, this time the "C" shaped taping technique will be adhered with 50% tension from the middle fibers of the trapezium to the last rib.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analogue Scale
Time Frame: 4 weeks
|
Visual Analogue Scale (VAS) will be used to assess pain severity.
In the assessment, the patient is asked to mark pain intensity on a 10-centimeter line that no pain is 0, and the most severe pain is 10.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fibromyalgia Impact Questionnaire
Time Frame: 4 weeks
|
The questionnaire assesses the functional status of patients with fibromyalgia.
The scale consists of 20 questions that measure physical function, well-being, difficulty in doing work, not being able to go to work, fatigue, stiffness, morning fatigue, pain, anxiety, and depression separately.
Low scores indicate improvement or less effect in patients.
|
4 weeks
|
McGill Pain Questionnaire
Time Frame: 4 weeks
|
The quality of the pain felt by the patients will be evaluated with the Short Form McGill Pain Questionnaire.
The level of severity felt by the patient is evaluated with a number scale (0=no, 1=mild, 2=moderate, 3=severe), and higher scores show severe pain intensity.
|
4 weeks
|
Beck's Depression Inventory
Time Frame: 4 weeks
|
The Beck's Depression Inventory (BDI) is a 21-item self-assessment scale that evaluates the patients' perceived depressive symptoms quantitatively and measures the symptoms of depression.
The higher scores indicate the severity of the patient's depression.
It has been suggested that those who score 17 and above on the BDI may constitute an at-risk group.
|
4 weeks
|
Short Form-36 Quality of Life Scale
Time Frame: 4 weeks
|
The scale assesses the quality of life.
The scale consists of 36 items evaluated in 8 separate subscales.
The score from each subscale is between 0-100, and a higher score indicates better quality of life.
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Rasmi Muammer, PhD, Yeditepe University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Actual)
June 30, 2023
Study Completion (Actual)
July 7, 2023
Study Registration Dates
First Submitted
June 1, 2023
First Submitted That Met QC Criteria
June 1, 2023
First Posted (Actual)
June 9, 2023
Study Record Updates
Last Update Posted (Actual)
July 11, 2023
Last Update Submitted That Met QC Criteria
July 9, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Fibromyalgia (Alias Study Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
University of AberdeenCompletedFibromyalgia | Fibromyalgia, Primary | Fibromyalgia, SecondaryUnited Kingdom
-
Eli Lilly and CompanyCompletedFibromyalgia, Primary | Fibromyalgia, SecondaryMexico
-
Rasmia ElgoharyNot yet recruiting
-
Spaulding Rehabilitation HospitalNot yet recruiting
-
Cairo UniversityNot yet recruiting
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
University of UtahTerminated
-
State University of New York - Upstate Medical...CompletedFibromyalgia, PrimaryUnited States
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Tel-Aviv Sourasky Medical CenterCompletedFibromyalgia (FM)Israel
Clinical Trials on Connective tissue massage
-
Hacettepe UniversityUnknownHeadache Disorders, PrimaryTurkey
-
Istanbul University-CerrahpasaBahçeşehir University; Yeditepe UniversityCompleted
-
Biruni UniversityCompleted
-
Eastern Mediterranean UniversityUnknown
-
Ankara Yildirim Beyazıt UniversityCompletedConnective Tissue Diseases | Migraine | Migraine Without Aura | Migraine With AuraTurkey
-
Halic UniversityActive, not recruitingCerebral Palsy | Chronic ConstipationTurkey
-
Ankara Yildirim Beyazıt UniversityNot yet recruiting
-
Presidio Ospedaliero di AsiagoCompleted
-
Ankara Yildirim Beyazıt UniversityNot yet recruiting
-
Seyda TOPRAK CELENAYUnknownNeck Pain MusculoskeletalTurkey